About Jiabao
Jiabao is a company based in Beijing (China) founded in 2011 by Feng Tao. Jiabao has raised $14.35 million across 3 funding rounds from investors including Apricot Capital, ShenZhen GTJA Investment Group and Shanghai Life Insurance. Jiabao operates in a competitive market with competitors including Celmatix, Metabolomic Diagnostics, Ovation Fertility, NX Prenatal and LIA Diagnostics, among others.
- Headquarter Beijing, China
- Founders Feng Tao
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$14.35 M (USD)
in 3 rounds
-
Latest Funding Round
$14.35 M (USD), Series B
Aug 10, 2020
-
Investors
Apricot Capital
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Jiabao
Jiabao has successfully raised a total of $14.35M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $14.35 million completed in August 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Jiabao
Jiabao has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Apricot Capital, ShenZhen GTJA Investment Group and Shanghai Life Insurance.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Jiabao
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Jiabao
Investment portfolio details for Jiabao
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Jiabao
Detailed financials for Jiabao
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Jiabao Comparisons
Peer comparison for Jiabao
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Jiabao
Jiabao operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Celmatix, Metabolomic Diagnostics, Ovation Fertility, NX Prenatal and LIA Diagnostics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Fertility decisions are optimized using data analytics and genomics.
|
|
| Locked | Locked | Locked |
Diagnostics and prognostics for maternal health are developed using metabolomics.
|
|
| Locked | Locked | Locked |
Genetic diagnostics for fertility centers are offered through molecular testing.
|
|
| Locked | Locked | Locked |
Early warning blood tests for pregnancy complications are provided.
|
|
| Locked | Locked | Locked |
Disposable paper pregnancy test kits
|
|
| Locked | Locked | Locked |
Clinical-grade diagnostic tests for home use are developed.
|
Detailed competitors of Jiabao
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Jiabao
Complete news archive for Jiabao
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jiabao
Jiabao was founded in 2011 and raised its 1st funding round 6 years after it was founded.
Jiabao is headquartered in Beijing, China.
Feng Tao is the current CEO of Jiabao. They have also founded this company.
Jiabao is a funded company, having raised a total of $14.35M across 3 funding rounds to date.
Beijing Jiabao Renhe Medical Technology was founded in 2011 and is based in Beijing, China. Operations focus on the assisted reproduction sector, where genetic testing technologies for pre-pregnancy, pre-implantation screening and diagnosis, prenatal, and neonatal applications are provided. Equipment, consumables, diagnostics, and reagents are supplied, along with bioinformatics analysis platforms and sequencing systems.
Jiabao's top competitors include Celmatix, NX Prenatal and Metabolomic Diagnostics.
Jiabao has 3 investors. Key investors include Apricot Capital, ShenZhen GTJA Investment Group, and Shanghai Life Insurance.